Literature DB >> 10227120

Monoclonal antibodies to the GP5 of porcine reproductive and respiratory syndrome virus are more effective in virus neutralization than monoclonal antibodies to the GP4.

E Weiland1, M Wieczorek-Krohmer, D Kohl, K K Conzelmann, F Weiland.   

Abstract

The arterivirus porcine reproductive and respiratory syndrome virus (PRRSV) contains six structural proteins the roles of which are not completely understood. In a preceding study, immunization with the dutch isolate I10 of PRRSV had led to the development of MAbs against four structural proteins [Wieczorek-Krohmer, M., 1994. Herstellung und Charakterisierung von monoklonalen Antikörpern gegen das Virus des Porzinen Reproduktiven und Respiratorischen Syndroms (PRRSV). Inaugural-Dissertation, Ludwig-Maximilians-Universität, München] here finally identified by reaction with individual plasmid-expressed PRRSV proteins as products of ORFs 3 (GP3), 4 (GP4), 5 (GP5) and 7 (N). Surprisingly, the MAbs against GP5 revealed the presence of two antigenically distinct virus populations in the isolate I10, the population PRRSV-'PPV', isolated from plaques and the PRRSV-'EPV', gained by end point dilution. MAbs against GP3, GP4 and N reacted with both I10 populations as well as with natural PRRSV isolates. However, the anti-GP5 MAbs exclusively recognized PRRSV-'PPV'. In this study immunization of mice with both separated I10 populations confirmed that solely PRRSV-'PPV' possesses the property to induce an immune response ultimately leading to the establishment of MAbs against GP5. Whereas the 15 anti-GP5 MAbs (derived from four independent fusions) reacted exclusively with PRRSV-'PPV' of the isolate I10, anti-GP4 MAbs detected their target antigen on various isolates of European origin and were able to neutralize them. As indicated by competition assays and selection of neutralization-resistant virus mutants, all GP5 MAbs are directed against a single antigenic site on the ORF 5 protein. Both groups of neutralizing antibodies bound to the surface of purified virions demonstrating that the recognized epitopes represent surface structures of the virion envelope. However, anti-GP5 MAbs mediated the binding of more gold granules than anti-GP4 MAbs. Comparison of the neutralizing effect of anti-GP4 and anti-GP5 MAbs revealed the anti-GP5 MAbs as the more efficient antibodies. For the complete neutralization of about 100 ID50 of PRRSV-'PPV' anti-GP5 culture supernatant was effective up to a dilution of 1:1280 whereas the most effective anti-GP4 antibodies exhibited a comparable effect only up to 1:64. These results indicate that PRRSV GP5 in principle is a major target for neutralizing antibodies, as is found for other arteriviruses, but that in nature 'ORF 5 escape mutants' may develop as easily as in vitro.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10227120     DOI: 10.1016/s0378-1135(99)00006-1

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  34 in total

1.  Monoclonal antibodies directed against conserved epitopes on the nucleocapsid protein and the major envelope glycoprotein of equine arteritis virus.

Authors:  E Weiland; S Bolz; F Weiland; W Herbst; M J Raamsman; P J Rottier; A A De Vries
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Molecular assessment of the role of envelope-associated structural proteins in cross neutralization among different PRRS viruses.

Authors:  Won-Il Kim; Kyoung-Jin Yoon
Journal:  Virus Genes       Date:  2008-09-03       Impact factor: 2.332

3.  Epitope mapping porcine reproductive and respiratory syndrome virus by phage display: the nsp2 fragment of the replicase polyprotein contains a cluster of B-cell epitopes.

Authors:  M B Oleksiewicz; A Bøtner; P Toft; P Normann; T Storgaard
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  Immune responses in pigs induced by recombinant canine adenovirus 2 expressing the glycoprotein 5 of porcine reproductive and respiratory syndrome virus.

Authors:  J-X Zhou; J-D Xue; T Yu; J-B Zhang; Y Liu; N Jiang; Y-L Li; R-L Hu
Journal:  Vet Res Commun       Date:  2010-04-30       Impact factor: 2.459

5.  Immune evasion of porcine reproductive and respiratory syndrome virus through glycan shielding involves both glycoprotein 5 as well as glycoprotein 3.

Authors:  Hiep L X Vu; Byungjoon Kwon; Kyoung-Jin Yoon; William W Laegreid; Asit K Pattnaik; Fernando A Osorio
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

6.  Involvement of the matrix protein in attachment of porcine reproductive and respiratory syndrome virus to a heparinlike receptor on porcine alveolar macrophages.

Authors:  P L Delputte; N Vanderheijden; H J Nauwynck; M B Pensaert
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

7.  Protective humoral immune response induced by an inactivated porcine reproductive and respiratory syndrome virus expressing the hypo-glycosylated glycoprotein 5.

Authors:  Jung-Ah Lee; Byungjoon Kwon; Fernando A Osorio; Asit K Pattnaik; Nak-Hyung Lee; Sang-Won Lee; Seung-Yong Park; Chang-Seon Song; In-Soo Choi; Joong-Bok Lee
Journal:  Vaccine       Date:  2014-05-09       Impact factor: 3.641

8.  Porcine arterivirus infection of alveolar macrophages is mediated by sialic acid on the virus.

Authors:  Peter L Delputte; Hans J Nauwynck
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

9.  Molecular mutations associated with the in vitro passage of virulent porcine reproductive and respiratory syndrome virus.

Authors:  Wei Han; Jia-Jun Wu; Xiao-Yu Deng; Zhen Cao; Xiu-Ling Yu; Chuan-Bin Wang; Tie-Zhu Zhao; Nan-Hua Chen; Hong-Hui Hu; Wang Bin; Li-Li Hou; Li-Lin Wang; Ke-Gong Tian; Zhong-Qiu Zhang
Journal:  Virus Genes       Date:  2009-01-09       Impact factor: 2.332

10.  Immune responses in mice vaccinated with virus-like particles composed of the GP5 and M proteins of porcine reproductive and respiratory syndrome virus.

Authors:  Hae-Mi Nam; Kyung-Sil Chae; Young-Jo Song; Nak-Hyung Lee; Joong-Bok Lee; Seung-Yong Park; Chang-Seon Song; Kun-Ho Seo; Sang-Moo Kang; Min-Chul Kim; In-Soo Choi
Journal:  Arch Virol       Date:  2013-02-08       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.